CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Trade Payables | ₹7.62 Cr | ₹3.10 Cr | ₹5.27 Cr | ₹7.18 Cr |
What is the latest Trade Payables ratio of CONCORD DRUGS ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹7.62 Cr |
| Mar2024 | ₹3.10 Cr |
| Mar2023 | ₹5.27 Cr |
| Mar2022 | ₹7.18 Cr |
How is Trade Payables of CONCORD DRUGS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.62 Cr | 145.79 | |
| Mar2024 | ₹3.10 Cr | -41.18 | |
| Mar2023 | ₹5.27 Cr | -26.56 | |
| Mar2022 | ₹7.18 Cr | - | |
Compare Trade Payables of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹96.2 Cr | -1.3% | 3.6% | 26.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -1.3% |
3.6% |
26.3% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses